跳转至内容
Merck
CN
  • Characterization of microRNAs differentially expressed during bovine follicle development.

Characterization of microRNAs differentially expressed during bovine follicle development.

Reproduction (Cambridge, England) (2014-06-13)
Sadanand D Sontakke, Bushra T Mohammed, Alan S McNeilly, F Xavier Donadeu
摘要

Several different miRNAs have been proposed to regulate ovarian follicle function; however, very limited information exists on the spatiotemporal patterns of miRNA expression during follicle development. The objective of this study was to identify, using microarray, miRNA profiles associated with growth and regression of dominant-size follicles in the bovine monovular ovary and to characterize their spatiotemporal distribution during development. The follicles were collected from abattoir ovaries and classified as small (4-8  mm) or large (12-17  mm); the latter were further classified as healthy or atretic based on estradiol and CYP19A1 levels. Six pools of small follicles and individual large healthy (n=6) and large atretic (n=5) follicles were analyzed using Exiqon's miRCURY LNA microRNA Array 6th gen, followed by qPCR validation. A total of 17 and 57 sequences were differentially expressed (greater than or equal to twofold; P<0.05) between large healthy and each of small and large atretic follicles respectively. Bovine miRNAs confirmed to be upregulated in large healthy follicles relative to small follicles (bta-miR-144, bta-miR-202, bta-miR-451, bta-miR-652, and bta-miR-873) were further characterized. Three of these miRNAs (bta-miR-144, bta-miR-202, and bta-miR-873) were also downregulated in large atretic follicles relative to large healthy follicles. Within the follicle, these miRNAs were predominantly expressed in mural granulosa cells. Further, body-wide screening revealed that bta-miR-202, but not other miRNAs, was expressed exclusively in the gonads. Finally, a total of 1359 predicted targets of the five miRNAs enriched in large healthy follicles were identified, which mapped to signaling pathways involved in follicular cell proliferation, steroidogenesis, prevention of premature luteinization, and oocyte maturation.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
咪唑, ReagentPlus®, 99%
Sigma-Aldrich
甲酰胺, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
咪唑, ACS reagent, ≥99% (titration)
Sigma-Aldrich
甲酰胺, ≥99.5% (GC), BioReagent, Molecular Biology
Sigma-Aldrich
咪唑, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
甲酰胺, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
1-(3-二甲基氨基丙基)-3-乙基碳二亚胺, ≥97.0% (T)
Sigma-Aldrich
咪唑, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
咪唑水溶液, BioUltra, 1 M in H2O
Sigma-Aldrich
咪唑, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
黄体酮, ≥99%
Sigma-Aldrich
黄体酮, meets USP testing specifications
Sigma-Aldrich
甲酰胺, ACS reagent, ≥99.5%
Sigma-Aldrich
甲酰胺, spectrophotometric grade, ≥99%
Sigma-Aldrich
咪唑, ≥99% (titration), crystalline
Sigma-Aldrich
咪唑, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
咪唑, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
咪唑, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
地高辛, analytical standard
USP
咪唑, United States Pharmacopeia (USP) Reference Standard
Supelco
甲酰胺 溶液, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
Sigma-Aldrich
咪唑, ReagentPlus®, 99%, Redi-Dri, free-flowing
咪唑, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
甲酰胺 溶液, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 10 mm × 8 in.
地高辛, European Pharmacopoeia (EP) Reference Standard
昂丹司琼杂质E, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
咪唑, Molecular Biology, ≥99% (titration), free-flowing, Redi-Dri
Supelco
甲酰胺 溶液, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
Sigma-Aldrich
甲酰胺, Vetec, reagent grade, 98%
Sigma-Aldrich
黄体酮, Vetec, reagent grade, 98%